Reuters - Merck & Co. said on Thursday first-quarter earnings rose as booming sales of newer prescription drugs offset declines in older products such as its Zocor cholesterol fighter.
Quarterly Profit is now at 78cents per share($1.7Billion), up from 69cents a year ago
No comments:
Post a Comment